Researchers in USC Viterbi’s Department of Biomedical Engineering have created a new nanoparticle that aims to prevent potentially deadly blood clots.
Treatments for COVID-19 would deliver up to $106 billion in gains by the end of 2021, a new analysis from the USC Schaeffer Center finds.
His game-changing play propelled the Trojans’ legendary comeback win over Notre Dame in their 1974 national championship season.
USC researchers found that exposure to flaring was associated with 50% higher odds of preterm birth.
Pedro Noguera, the new dean of the USC Rossier School of Education, answers questions about his Brooklyn upbringing and what the pandemic has taught us about education.
The Department of Homeland Security on Tuesday agreed to rescind its directive that would have required international students to take in-person classes to maintain their visa status.
The tool, created by a team at the Gehr Family Center for Health Systems Science and Innovation, found that only 20% of users reported symptoms that required immediate medical attention.
Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the drug DAS181 as a treatment for hospitalized patients with severe COVID-19.
